Get the Stockscreener App
10.00
0.10%
-0.010
After Hours:
10.00
New America Acquisition I Corp stock is traded at $10.00, with a volume of 37,723.
It is down -0.10% in the last 24 hours and down -0.70% over the past month.
New America Acquisition I Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, which it refers to throughout this prospectus as its initial Business Combination.
See More
Previous Close:
$10.01
Open:
$10.02
24h Volume:
37,723
Relative Volume:
0.45
Market Cap:
$498.00M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
1,052.63
EPS:
0.0095
Net Cash Flow:
-
1W Performance:
-0.10%
1M Performance:
-0.70%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.00
$10.03
1-Week Range:
$9.99
$10.04
52-Week Range:
$9.675
$10.25
New America Acquisition I Corp Stock (NWAX) Company Profile
Name
New America Acquisition I Corp
Sector
Industry
Phone
212-970-5150
Address
590 MADISON AVENUE, NEW YORK
Compare NWAX vs LION, XXI, MTAL, UMAC, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NWAX
New America Acquisition I Corp
|
10.00 | 498.50M | 0 | 0 | 0 | 0.0095 |
LION
Lionsgate Studios Corp
|
10.66 | 3.22B | 2.80B | -224.60M | -1.10M | -0.8751 |
XXI
Twenty One Capital Inc
|
7.40 | 2.55B | 0 | 4.35M | 456.40K | 0.3397 |
MTAL
Metals Acquisition Corp Ii
|
10.01 | 1.01B | 0 | -24.35M | -3.33M | -0.6869 |
UMAC
Unusual Machines Inc
|
15.42 | 668.55M | 11.20M | -19.19M | -23.24M | -0.7527 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.00 | 656.41M | 0 | 0 | 0 | -0.0028 |
New America Acquisition I Corp Stock (NWAX) Latest News
TRG Latin America Acquisitions Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing April 20, 2026 - The Manila Times
JPMorgan Chase & Co. Buys Shares of 99,690 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
200,000 NWAX shares bought via entity tied to New America (NWAX) director - Stock Titan
Drugs Made In America Acquisition Corp.Rights (NQ: DMAAR - The Chronicle-Journal
Drugs Made in America Acquisition Corp. signs LOI for de-SPAC with Power Analytics - Investing.com UK
Proem Acquisition Corp I: Performance & Quotes, PAAC Stock Price on Nasdaq Exchange - marketscreener.com
New America Acquisition I Corp. Stock Forecast Summary - Meyka
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement By Investing.com - Investing.com South Africa
Drugs Made In America Acquisition II Corp. enters $300,000 convertible note agreement - Investing.com
$300K zero‑interest note backs Drugs Made In America II (NASDAQ: DMII) - Stock Titan
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
Cambridge Acquisition Corp.: Performance & Quotes, CAQ Stock Price on Nasdaq Exchange - marketscreener.com
New America 10-K: $0.0M Revenue; Net income $0.478M (no EPS disclosed) - tradingview.com
New America Acquisition I Corp. Reports Earnings Results for the Seven Months Ended December 31, 2025 - marketscreener.com
New America Acquisition I (NYSE: NWAX) outlines $345M SPAC structure - Stock Titan
Renatus Tactical Acquisition Corp I (RTAC) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
FGNA.WS (FG New America Acquisition) PB Ratio : (As of Mar. 31, 2026) - GuruFocus
Drugs Made In America Acquisition Corp. issues $100,000 convertible note as part of $500,000 financing - Investing.com Australia
A&O Shearman guides underwriter on TRG Latin America Acquisitions Corp.’s SPAC IPO - A&O Shearman
TRG Latin America's IPO grows to $206.3M after underwriter buys more units - Stock Titan
Complete List of Financial ServicesDiversified Financial ServicesShell Companies Stocks - GuruFocus
14,375,000 Ordinary Shares of Drugs Made In America Acquisition II Corp. are subject to a Lock-Up Agreement Ending on 23-MAR-2026. - marketscreener.com
Stefan Passantino Net Worth (2026) - GuruFocus
Polar Asset Management Partners Inc. Purchases New Position in American Exceptionalism Acquisition Corp. $AEXA - MarketBeat
Drugs Made In America II (NASDAQ: DMII) plans $1.4M convertible note funding - Stock Titan
Dominari Holdings addresses congressional inquiry on Chinese IPOs - Investing.com
Dominari says IPOs are under 10% of revenue as House panel asks on China - Stock Titan
Boothbay Fund Management LLC Sells 70,000 Shares of Drugs Made In America Acquisition Corp. $DMAA - Defense World
Donald Trump Jr. and Eric Trump back drone company Powerus - qz.com
Clear Street Group Inc. Acquires New Holdings in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Boothbay Fund Management LLC Buys New Position in American Exceptionalism Acquisition Corp. $AEXA - MarketBeat
Radcliffe Capital Management L.P. Has $5.42 Million Position in Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Trump’s sons back new military drone venture tied to Pentagon work - Moneycontrol.com
Trump sons back launch of new military drone company - Financial Times
$50M KCGI bet, Trump investors behind new U.S. drone merger plan - Stock Titan
Drugs Made In America Acquisition II Corp. confirms trust account balance after review - Investing.com South Africa
[8-K] Drugs Made In America Acquisition II Corp. Reports Material Event | DMII SEC FilingForm 8-K - Stock Titan
Drugs Made In America Acquisition Corp. appoints new CEO after board changes - Investing.com Australia
Drugs Made In America Acquisition II Corp. appoints new CEO after sponsor repayment issue - Investing.com
CEO exits Drugs Made In America (NASDAQ: DMAA) after affiliate fund withdrawals - Stock Titan
Sponsor overpayment leads to CEO change at Drugs Made In America II (DMII) - Stock Titan
Context Capital Management LLC Buys Shares of 250,000 Drugs Made In America Acquisition Corp. $DMAA - MarketBeat
Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) Short Interest Down 21.7% in February - MarketBeat
TRG Latin America Acquisitions Corp. Completes $200 Million Initial Public Offering - The Manila Times
New $200M Nasdaq listing bundles TRG Latin America shares with rights - Stock Titan
TRG Latin America Acquisitions Corp. Announces Pricing of $200 Million Initial Public Offering - The Manila Times
New America Acquisition I Corp Stock (NWAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.18%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):